FDA Investigator M A Abel I
M A Abel I has conducted inspections on 13 sites in 4 countries as of 18 May 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
13
Last Inspection Date:
18 May 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Canada,
China,
France,
United States of America
FDA Investigators that have inspected at least one site in common with M A Abel I:
Amanda K Willey,
Anna E Fain,
Barbara D Wright,
Barbara S Manson,
Beira Montalvo,
Bonnie E Conley,
Bonnie E Pierson,
Brian D Nicholson,
Cheryl G Scott,
Christophe L Boulmay,
Christopher J Adams,
Clara E Santiago,
Clendening,
Cody D Rickman,
Colleen E Burke,
Combs,
Dana M Klimavicz,
Danielle M Maddox,
David J Leray,
Dennis Cantellops Paite,
Donna D Gallien, MPH,
Dr. Robert C Horan, MD,
Dwayne A Miller,
Eddie J Rigsby,
Elizabeth D Connell,
Erica M Katherine,
Francis A Guidry,
George J Flynn,
James To Neal,
James W Blakely,
Jason P Aun,
Jeanne J Thai,
Jennifer Caycedo,
Jessica A Stephens,
Joanne E King,
John A Iwen,
Juanelma H Palmer,
Justin N Henson,
Karen Gale Sego,
Karen M Rodriguez,
Kari L Batey,
Katherine M Taylor,
Katherine Szestypalow,
Kelly M Byers,
Kenneth R Merritt,
Kevin D Kallander,
Kimberly A Dutzek,
Kip J Hanks,
Krista W Whitten,
Lacey J Chessor,
Lacey J Rice,
Larry A Estavan,
Llopis,
Mahaffey,
Marie F Morin,
Markeesa M Scales,
Marlene L Davis,
Melanie L Drayton,
Regina T Brown,
Richard E Needham,
Richmond K Yip,
Robert E Hultman,
Sally Gopaul,
Susan P Bruederle,
Thomas B Smith,
Thomas R Stanley,
Tiana M Mckinley,
Wanda B Coats,
Whitney M White,
Xikui Chen (nmi), PhD,
Yuanyuan Li
M A Abel I's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2008 | EIR | PharmaNet Canada Inc - EIR, 2015-09-01 |
April, 2004 | FDA 483 Response | Suzhou no. 4 Pharmaceutical Factory - Form 483R, 2004-05-03 |
June, 2011 | EIR | Sunandana Chandra, M.D. - EIR, 2011-06-17 |
April, 2004 | FDA 483 | Suzhou no. 4 Pharmaceutical Factory - Form 483, 2004-04-01 |
March, 2006 | EIR | Cetero Research - EIR, 2006-03-01 |
April, 2004 | EIR | Suzhou no. 4 Pharmaceutical Factory - EIR, 2004-05-13 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more